February 13, 2026 · Form 4 insider transaction
GORMAN KEVIN CHARLES sold 3,024 shares of Neurocrine Biosciences, Inc. at $124.12 per share, a transaction worth $375.3K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 4 days after the transaction.
Shares withheld by Neurocrine Biosciences, Inc. (the "Company" or "Issuer") to satisfy tax withholding requirements on vesting of restricted stock units ("RSUs") or performance restricted stock units ("PRSUs"), as applicable. No shares were sold.